QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gokce, N. Search for Related Content PubMed PubMed Citation Articles by Gokce, N.

---

Supplement: Arginine Metabolism: Enzymology, Nutrition, and Clinical Significance

L-Arginine and Hypertension^1,2

Evans Department of Medicine, Cardiology Section, and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118

³To whom correspondence should be addressed. E-mail: Noyan.Gokce{at}bmc.org.

Hypertension is a major healthcare problem afflicting nearly 50 million individuals in the United States. Despite its strong causal association with cardiovascular disease complications including myocardial infarction, heart failure, and stroke, the majority of patients with hypertension do not achieve optimal blood pressure control. The prevalence of hypertension is expected to increase with the aging population, growing obesity epidemic, and rising incidence of metabolic syndrome. Endothelial dysfunction and reduced nitric oxide (NO) bioactivity represent prominent pathophysiological abnormalities associated with hypertensive cardiovascular disease. Individuals with hypertension exhibit blunted epicardial and resistance vascular dilation to endothelium-derived nitric oxide (EDNO) agonists in the peripheral and coronary circulation that likely contributes to mechanisms of altered vascular tone in hypertension. The amino acid L-arginine serves as the principal substrate for vascular NO production. Numerous studies, though not uniformly, demonstrate a beneficial effect of acute and chronic L-arginine supplementation on EDNO production and endothelial function, and L-arginine has been shown to reduce systemic blood pressure in some forms of experimental hypertension. This brief review discusses the potential role of L-arginine in hypertension, and reviews possible mechanisms of L-arginine action including modulation of EDNO production, alteration of asymmetrical dimethylarginine (ADMA):L-arginine balance, and possible improvement of insulin sensitivity. In view of the rising prevalence of hypertension, randomized human clinical studies investigating the potential therapeutic role of L-arginine may be warranted.

KEY WORDS: • L-arginine • hypertension • endothelium • nitric oxide

This article has been cited by other articles:

				S. J. Nicholls, Z. Wang, R. Koeth, B. Levison, B. DelFraino, V. Dzavik, O. W. Griffith, D. Hathaway, J. A. Panza, S. E. Nissen, et al. Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction Circulation, November 13, 2007; 116(20): 2315 - 2324. [Abstract] [Full Text] [PDF]

				C. Nieves Jr, H. S. Sitren, K. A. Herrlinger-Garcia, and B. Langkamp-Henken Pharmacologic Levels of Dietary Arginine in CB6F1 Mice Increase Serum Ammonia in the Healthy State and Serum Nitrite in Endotoxemia JPEN J Parenter Enteral Nutr, March 1, 2007; 31(2): 101 - 108. [Abstract] [Full Text] [PDF]

				J. W. Younger, K. A. Lawler-Row, K. A. Moe, A. L. Kratz, and A. J. Keenum Effects of naltrexone on repressive coping and disclosure of emotional material: a test of the opioid-Peptide hypothesis of repression and hypertension. Psychosom Med, September 1, 2006; 68(5): 734 - 741. [Abstract] [Full Text] [PDF]

				C. Baylis Session III: Arginine and Pathophysiology I--Discussion Summary J. Nutr., October 1, 2004; 134(10): 2818S - 2819S. [Full Text] [PDF]